With this contracting file whose conditions are established in the specifications, it is intended to cover the use of the medicine included in the file to meet the clinical needs of Osakidetza patients and related centers and which are summarized in the report's memory.

Active substance: Aciclovir (DOE)

Amount of active substance: 250 mg

Pharmaceutical form: vial or vial

Packaging conditions: unit dose

Maximum unit price: EUR 2.00 / vial or vial

Number of units planned: 37,000 vials or ampoules

Maximum estimated budget: EUR 74,000.00 (first year of contract)

Active substance: Rocuronium (DOE)

Amount of active substance: 50 mg

Pharmaceutical form: vial

Packaging conditions: unit dose

Maximum unit price: EUR 6.48 / 5 vials (Taxes not included)

Number of units planned: 92,000 vials

Maximum estimated budget: EUR 119 232.00 (first year of contract)

Active ingredient: Human Coagulation Factor (DOE) IX

Amount of active substance: 1,200 IU

Pharmaceutical form: vial

Packaging conditions: unit dose

Maximum unit price: EUR 480.29 / vial (Taxes not included)

Number of planned units: 600 vials

Estimated maximum budget: EUR 288 174.00 (first year of contract)

Active substance: Rabbit immunoglobulin human antithymocytes (DOE)

Amount of active substance: 25 mg

Pharmaceutical form: vial

Packaging conditions: unit dose

Maximum unit price: EUR 126.84 / vial (Taxes not included)

Number of planned units: 1,500 vials

Maximum estimated budget: 190,260.00 EUR (first year of contract)